Brought to you by 
Health and biology company Verily Life Sciences receives $800mm investment from Temasek
15 Sep 2017
Executive Summary
Verily Life Sciences LLC (research and engineering company focusing on improving health outcomes) received an $800mm investment from Singapore investment company Temasek in exchange for a minority stake in the company (also appoints one director to company's board). The two companies will also collaborate on expanding Verily's programs outside of the US.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
- Monitoring Equipment & Devices
-
In Vitro Diagnostics
- Biosensors
- Glucose Testing
-
Biotechnology
- Nanotechnology, Chips, etc.
-
Drug Discovery Tools
- Genomics-Proteomics
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Health and biology company Verily Life Sciences receives $800mm investment from Temasek
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice